A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL
Indiana University
Indiana University
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Columbia University
University of Washington
University of Washington
Mayo Clinic
Mayo Clinic
National Cancer Institute (NCI)
Celldex Therapeutics
OHSU Knight Cancer Institute
Icahn School of Medicine at Mount Sinai
Corvus Pharmaceuticals, Inc.
National Institutes of Health Clinical Center (CC)
Sunnybrook Health Sciences Centre
Seagen Inc.
Merck Sharp & Dohme LLC
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Western Regional Medical Center